Zidovudine and interferon therapy for adult T-cell leukaemia/lymphoma. Results of a preliminary study at UHWI-Mona
- PMID: 9033228
Zidovudine and interferon therapy for adult T-cell leukaemia/lymphoma. Results of a preliminary study at UHWI-Mona
Abstract
Seven patients with adult T-cell leukaemia/lymphoma (ATL) were treated with a combination of zidovudine (AZT) and interferon after failed chemotherapy. One patient showed a major response for nine months. The remainder showed progressive disease further complicated by drug toxicity. The poor responses could be explained by patient selection, since most patients had advanced disease refractory to chemotherapy. A larger more protracted study is required for further evaluation of this treatment option.
Similar articles
-
A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.Hematol J. 2002;3(6):276-82. doi: 10.1038/sj.thj.6200195. Hematol J. 2002. PMID: 12522449 Clinical Trial.
-
Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: efficacy of anti-retroviral and interferon therapy.Am J Hematol. 2004 Jun;76(2):187-9. doi: 10.1002/ajh.20065. Am J Hematol. 2004. PMID: 15164389
-
A case of adult T-cell leukemia/lymphoma (ATL) with a survival of more than 13 years.Acta Oncol. 2008;47(5):981-3. doi: 10.1080/02841860701704732. Acta Oncol. 2008. PMID: 18568490 No abstract available.
-
Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S186-90. doi: 10.1097/00042560-199600001-00028. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8797722 Review.
-
[Interferon therapy of infectious diseases: the state of the problem and prospects].Zh Mikrobiol Epidemiol Immunobiol. 2005 Nov-Dec;(6):94-9. Zh Mikrobiol Epidemiol Immunobiol. 2005. PMID: 16438387 Review. Russian.
Cited by
-
Advances in interleukin 2 receptor targeted treatment.Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i109-14. doi: 10.1136/ard.59.suppl_1.i109. Ann Rheum Dis. 2000. PMID: 11053100 Free PMC article. Review.
-
HTLV-1 infections.J Clin Pathol. 2000 Aug;53(8):581-6. doi: 10.1136/jcp.53.8.581. J Clin Pathol. 2000. PMID: 11002759 Free PMC article. Review.